Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Risk of tuberculosis reactivation with interleukin (IL)‐17 and IL‐23 inhibitors in psoriasis – time for a paradigm change

PaperCitations, authors & open-access status

Risk of tuberculosis reactivation with interleukin (IL)‐17 and IL‐23 inhibitors in psoriasis – time for a paradigm change is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 95 citations, 2020 year and closed oa status.

95
Citations
2020
Year
closed
OA Status

Related on ScholarIQ

Tiago Torres
Author
Journal of the European Academy of Dermatology and Venereology
Journal
Psoriasis: Treatment and Pathogenesis
Topic
Psoriasis: Treatment and Pathogenesis
Topic
Tuberculosis Research and Epidemiology
Topic
Immunodeficiency and Autoimmune Disorders
Topic
470M+ articles · free account